UBS analyst Sasha Sanwal lowered his price target on Halliburton to $50 from $60 following its worse than expected Q4 guidance. The analyst was surprised by the sequential decline in guidance in the North American market, but noted its International market appears more promising. Given the uncertainty around the North American market, the analyst lowered his estimates and price target. Sanwal maintained her Buy rating on Halliburton shares, but said he would wait for more clarity on the North American recovery before taking advantage of the near-term softness in the shares.

Unusual total active option classes on open include: ImmunityBio (IBRX), Halliburton (HAL), Redfin (RDFN), Nokia (NOK), Matterport (MTTR), General Motors (GM), UPS (UPS), Philip Morris (PM), PepsiCo (PEP), and General Electric (GE).

Reports Q1 revenue $5.8B, consensus $5.67B. "Halliburton delivered solid first quarter results that again demonstrated the power of our strategy and the strength of our execution. Activity in North America recovered from fourth-quarter lows, and our international business delivered its 11th consecutive quarter of year-on-year growth," commented Jeff Miller, Chairman, President and CEO. "Our customers' multi-year activity plans across markets and asset types confirms my confidence in the strength and duration of this upcycle. Halliburton demonstrated its commitment to shareholder returns in the first quarter and repurchased $250 million of common stock - a solid start to the year and a good benchmark for our expectations going forward," concluded Miller.